利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎中的轻度新型冠状病毒肺炎 - Suppr

Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.

作者信息

Suárez-Díaz Silvia, Morán-Castaño Claudia, Coto-Hernández Rubén, Mozo-Avellaneda Lourdes, Suárez-Cuervo Carlos, Caminal-Montero Luis

机构信息

Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain

Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

出版信息

Ann Rheum Dis. 2021 Jun;80(6):e99. doi: 10.1136/annrheumdis-2020-218246. Epub 2020 Aug 7.

DOI:10.1136/annrheumdis-2020-218246

PMID:32769153

Abstract

摘要

相似文献

Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎中的轻度新型冠状病毒肺炎

Ann Rheum Dis. 2021 Jun;80(6):e99. doi: 10.1136/annrheumdis-2020-218246. Epub 2020 Aug 7.

COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab.2019冠状病毒病与抗中性粒细胞胞浆抗体相关性血管炎：疫苗接种准备及利妥昔单抗使用建议

Nephrol Dial Transplant. 2021 Aug 27;36(9):1758-1760. doi: 10.1093/ndt/gfab174.

Maintenance of remission of ANCA vasculitis by rituximab based on B cell repopulation versus serological flare: a randomised trial.基于 B 细胞再填充与血清学爆发的利妥昔单抗维持 ANCA 血管炎缓解：一项随机试验。

Ann Rheum Dis. 2024 Feb 15;83(3):351-359. doi: 10.1136/ard-2023-224489.

Response to: 'Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'' by Parikh .对帕里克的《关于“利妥昔单抗作为抗中性粒细胞胞浆抗体相关性血管炎复发后诱导缓解的治疗方法”的通信》的回复

Ann Rheum Dis. 2023 Jan;82(1):e24. doi: 10.1136/annrheumdis-2020-219329. Epub 2021 Feb 4.

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.抗中性粒细胞胞质抗体相关性垂体血管炎肾缓解后无抗中性粒细胞胞质抗体升高的异位复发。

Intern Med. 2020 Dec 15;59(24):3187-3193. doi: 10.2169/internalmedicine.4731-20. Epub 2020 Aug 12.

Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan.在使用阿伐考帕尼治疗难治性 ANCA 相关性血管炎的患者中实现了肾脏改善和缓解。

J Nephrol. 2023 Nov;36(8):2365-2370. doi: 10.1007/s40620-023-01614-y. Epub 2023 Apr 10.

Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis.评估利妥昔单抗治疗抗中性粒细胞胞浆抗体相关性血管炎后 PR3-ANCA 状态。

J Clin Rheumatol. 2019 Aug;25(5):217-223. doi: 10.1097/RHU.0000000000001030.

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.利妥昔单抗治疗的抗中性粒细胞胞浆抗体相关性血管炎患者对新冠病毒加强疫苗的抗体反应

Kidney Int. 2022 Feb;101(2):414-415. doi: 10.1016/j.kint.2021.11.012. Epub 2021 Nov 22.

c-ANCA-associated vasculitis with predominant CNS demyelination after COVID-19.COVID-19 后以中枢神经系统脱髓鞘为主的 c-ANCA 相关性血管炎。

Arch Pediatr. 2023 Jan;30(1):74-76. doi: 10.1016/j.arcped.2022.11.017. Epub 2022 Nov 30.

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Fcγ 受体和细胞色素 P450 酶的遗传关联与抗中性粒细胞胞质抗体相关性血管炎患者对利妥昔单抗或环磷酰胺治疗反应的相关性。

Arthritis Rheumatol. 2017 Jan;69(1):169-175. doi: 10.1002/art.39822.

引用本文的文献

B lymphocytes in COVID-19: a tale of harmony and discordance.COVID-19 中的 B 淋巴细胞：一个和谐与失调的故事。

Arch Virol. 2023 Apr 29;168(5):148. doi: 10.1007/s00705-023-05773-y.

More difficult still: Treating severe rapidly progressive glomerulonephritis in the context of COVID-19 pneumonia.更困难的是：在 COVID-19 肺炎的背景下治疗严重的快速进行性肾小球肾炎。

Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):94-98. doi: 10.1016/j.nefroe.2020.12.007. Epub 2022 Feb 17.

CoVITEST: A Fast and Reliable Method to Monitor Anti-SARS-CoV-2 Specific T Cells From Whole Blood.CoVITEST：一种从全血中快速可靠地监测抗 SARS-CoV-2 特异性 T 细胞的方法。

Front Immunol. 2022 Jul 5;13:848586. doi: 10.3389/fimmu.2022.848586. eCollection 2022.

COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry.COVID-19 与肾小球疾病患者：IRoc-GN 国际登记研究的随访结果。

Kidney360. 2021 Dec 3;3(2):293-306. doi: 10.34067/KID.0006612021. eCollection 2022 Feb 24.

Alopecia in patients with COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者的脱发：一项系统评价与荟萃分析

JAAD Int. 2022 Jun;7:67-77. doi: 10.1016/j.jdin.2022.02.006. Epub 2022 Feb 22.

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.2019冠状病毒病与免疫介导的炎症性疾病：疾病及治疗对2019冠状病毒病结局和疫苗反应的影响

Lancet Rheumatol. 2021 Oct;3(10):e724-e736. doi: 10.1016/S2665-9913(21)00247-2. Epub 2021 Aug 27.

COVID-19 pneumonia in a patient with granulomatosis with polyangiitis on rituximab: case-based review.利妥昔单抗治疗肉芽肿性多血管炎后 COVID-19 肺炎 1 例报告

Rheumatol Int. 2021 Aug;41(8):1509-1514. doi: 10.1007/s00296-021-04905-4. Epub 2021 Jun 6.

COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.接受B细胞耗竭疗法的患者和体液免疫缺陷状态患者的COVID-19结局：一项范围综述

Pathog Immun. 2021 May 14;6(1):76-103. doi: 10.20411/pai.v6i1.435. eCollection 2021.

Autoimmune connective tissue diseases in the COVID-19 pandemic.COVID-19 大流行中的自身免疫性结缔组织病。

Clin Dermatol. 2021 Jan-Feb;39(1):56-63. doi: 10.1016/j.clindermatol.2020.12.013. Epub 2020 Dec 15.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.接受利妥昔单抗治疗的炎症性风湿和肌肉骨骼疾病患者的COVID-19结局：一项队列研究。

Lancet Rheumatol. 2021 Jun;3(6):e419-e426. doi: 10.1016/S2665-9913(21)00059-X. Epub 2021 Mar 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mild COVID-19 in ANCA-associated vasculitis treated with rituximab.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献